Zaineb H. Makhzoumi, MD, MPH

Medical School: University of Maryland School of Medicine, Baltimore, MD

Internship: Mercy Medical Center, Baltimore, MD

Residency: University of Virginia, Charlottesville, VA

Fellowship: University of California, San Francisco, San Francisco, CA

Dr. Makhzoumi is a dermatologic surgeon at the University of Maryland School of Medicine. She specializes in the advanced technique of Mohs Micrographic Surgery and surgical reconstruction for skin cancer. A major focus of both her clinical practice and research efforts is the behavior and management of non-melanoma skin cancer in solid organ transplant recipients. A large portion of her practice is devoted to the care of these patients at particularly high risk for skin cancer. Her expertise also includes all aspects of procedural dermatology, including laser surgery and the rejuvenation of aging skin.

As Chief of Clinical Services in the Department of Dermatology, Dr. Makhzoumi oversees all aspects of clinical operations for the department. She is also responsible for the recruitment of new faculty, the expansion of clinical opportunities for the department and the development of collaborative projects across campus, particularly those focused on Cutaneous Oncology.

Dr. Makhzoumi received her BS in Biology and her MPH in Epidemiology and Biostatistics from the George Washington University. She went on to receive her MD from the University of Maryland School of Medicine, where she graduated magna cum laude and was the recipient of the 2008 Faculty Gold Medal Award. She received her training in dermatology at the University of Virginia, where she also served as chief resident, and her fellowship in Mohs Micrographic Surgery and Procedural Dermatology at the University of California San Francisco.

Non-melanoma skin cancer in solid organ transplant recipients, tumor management in the immunosuppressed, Mohs Micrographic Surgery

1. Meade C, Halvorson C, Kao G, Makhzoumi Z. Acute graft-versus-host disease arising within tattooed skin. Journal of the American Academy of Dermatology. 2015 May 2;1(3)114-6.

2. Meade C, Smith S, Makhzoumi Z. Eruptive keloids associated with aromatase inhibitor therapy. Journal of the American Academy of Dermatology. 2015 May 2;1(3)112-3.

3. He SY, Makhzoumi ZH, Singer JP, Chin-Hong PV, Arron ST. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey. Transplant Infect Dis. 2015 Feb; 17(1): 14-20.

4. Makhzoumi Z, and Arron SA. Commentary: Photosensitizing agents and the risk of non-melanoma skin cancer: A population based case-control study. Journal of Investigative Dermatology. 2013 Aug; 133(8):1922-3.

5. Makhzoumi Z, Decapite T, Gaspari A. Development of Beau’s Lines in two patients receiving azathioprine. Journal of Dermatologic Treatment. 2009;20(4): 246-7.

6. Makhzoumi Z, McLean L, Ibe A. Diabetic Ketoacidosis associated with aripiprazole. Pharmacotherapy. 2008 Sep;28(9) 1198-202.

7. Yentzer BA, Yelverton CB, Pearce DJ, Camacho FT, Makhzoumi Z, Clark A, Boles A, Fleischer AB Jr, Balkrishnan R, Feldman SR. Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. Journal of the American Academy of Dermatology. 2008 Oct;59(4): 577-81.